Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Plexus Corp's revenue performance in the Healthcare/Life Sciences segment reflects a positive trajectory, with a year-over-year increase of 5% for the full year, culminating in $1.629 billion, and expectations of high-single- to low-double-digit growth driven by multiple program ramps in the upcoming quarters. The Aerospace and Defense segment is positioned for sequential growth in FQ1, underpinning the company's goal of 9-12% revenue growth company-wide, bolstered by increases in commercial air and defense-related programs. Overall, Plexus's strategic focus on integrated lifecycle solutions across demanding sectors is supported by strong customer demand recovery, which positions the company for sustainable earnings growth beyond revenue metrics.

Bears say

Plexus Corp's gross margin decreased to 9.9% from 10.1% in the prior quarter, indicating potential challenges in cost management and pricing power. Additionally, the Aerospace & Defense segment, contributing 16% of total revenues, experienced a 6% decline both quarter-over-quarter and year-over-year, reflecting ongoing issues in demand. Furthermore, the company anticipates a high-single-digit decrease in Industrial revenues in the next quarter due to seasonality and moderating demand, coupled with broader economic concerns such as tariff pressures and risks related to manufacturing disruptions.

Plexus (PLXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 4 analysts, Plexus (PLXS) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $157.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $157.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.